Popular weight-loss drugs are now changing how Americans eat. Medications like Ozempic and Wegovy, known as GLP-1 drugs, greatly reduce a person’s appetite. About 12% of US adults have used these drugs for weight loss. This massive shift is now reshaping the entire food industry.
Restaurants are quickly adapting to new diner needs. Many people want smaller portion sizes. This is partly due to the drugs, and partly due to high inflation. Some chains are now testing smaller plates. Some high-end chefs offer special “Ozempic menus.” This allows customers to enjoy dining out without wasting food. This trend is normalizing smaller portions for all consumers.
The grocery and snack industries are also pivoting fast. Companies are heavily promoting high-protein foods. GLP-1 drug users often prioritize protein intake. For example, Nestlé has launched frozen meals tailored for these users. Meanwhile, sales of traditional processed snacks and sugary sodas are expected to decline. Food brands and retailers must adapt to this major change in consumer habits.
